Managing Atopic Dermatitis: Clinical Considerations, Payer Perspective, and 2024 Guidelines
A Q&A With Jonathan Silverberg, MD, PhD, MPH
A Q&A With Maria Lopes, MD, MS
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
2
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
3
Bumetanide Nasal Spray Targets Heart Failure Edema Before IV
4
Timing COVID-19 Protection With VYD2311: Michael Mina, MD, PhD
5